[Surgery for non-small cell lung cancer]

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1525-6.
[Article in Norwegian]


Background: As part of an evaluation of the lung cancer surgery at Akershus University hospital we wanted to describe the lung cancer surgery programme, assess 30-day mortality and review complications.

Material and method: We retrospectively examined medical records of all patients undergoing potentially curative surgery for non-small-cell lung cancer.

Results: The 99 patients operated on were aged 37-83 years (mean 63 years). 31% were women. 30-day mortality was 5% in total; 4% for lobectomy and 8% for pneumonectomy. No complication was recorded in 68% of the cases.

Interpretation: Age and gender distribution in the sample was in line with the experience of others. The results were in accordance with international recommendations, for example from the British Thoracic Society: 30-day mortality not in excess of 4% for lobectomy and 8% for pneumonectomy.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Female
  • Humans
  • Lung / surgery
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Pneumonectomy / adverse effects
  • Postoperative Complications / mortality
  • Pulmonary Surgical Procedures / adverse effects
  • Pulmonary Surgical Procedures / methods
  • Retrospective Studies
  • Survival Analysis